Medicine

Mefloquine

Indications: This medicine is an antimalarial agent used to treat or prevent malaria caused by Plasmodium falciparum, which is resistant to other antimalarial agents.

Directions for use: Treatment of malaria is initial 750 mg followed by 250 mg given eight hours later. For prevention of malaria the dosage is 250 mg given once a week starting one week before departure and terminating four weeks after leaving malaria- regions.

Pregnancy: may not be used.

Side effects: may include dizziness, nausea, and loss of appetite, stomach pain, diarrhoea, or headache. If they continue or are bothersome, check with your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience vomiting, rash, ringing in the ears, muscle pain, seizures, confusion, emotional or mood changes, agitation, or hallucinations. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.

Mefloquine Resource:

Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development.
De Paepe ME, Gundavarapu S, Tantravahi U, Pepperell JR, Haley SA, Luks FI, Mao Q.
Am J Pathol. 2008 Jul;173(1):42-56. Epub 2008 Jun 5
Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution.
Das AT, Klaver B, Centlivre M, Harwig A, Ooms M, Page M, Almond N, Yuan F, Piatak M Jr, Lifson JD, Berkhout B.
Retrovirology. 2008 Jun 5;5:44
[Cat-scratch disease localisation in the parotid gland].
Ben Slama L, Hasni W, Royer B.
Rev Stomatol Chir Maxillofac. 2008 Jun;109(3):183-6. Epub 2008 Jun 3. French.
Recurrent giant chalazia in hyperimmunoglobulin E (Job's) syndrome.
Patteri P, Serru A, Chessa ML, Loi M, Pinna A.
Int Ophthalmol. 2009 Oct;29(5):415-7. Epub 2008 Jun 5
Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.
Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH.
J Clin Microbiol. 2008 Aug;46(8):2499-507. Epub 2008 Jun 4
The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis.
Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, Xia Y, Puga A.
Mol Biol Cell. 2008 Aug;19(8):3263-71. Epub 2008 Jun 4
Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection.
Bhengraj AR, Dar SA, Talwar GP, Mittal A.
Int J Antimicrob Agents. 2008 Jul;32(1):84-8. Epub 2008 Jun 4
Promiscuous expression of H2B-GFP transgene in hematopoietic stem cells.
Challen GA, Goodell MA.
PLoS One. 2008 Jun 4;3(6):e2357
Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients.
Sawalha AH, Jeffries M, Webb R, Lu Q, Gorelik G, Ray D, Osban J, Knowlton N, Johnson K, Richardson B.
Genes Immun. 2008 Jun;9(4):368-78
Management of neurobrucellosis: an assessment of 11 cases.
Gul HC, Erdem H, Gorenek L, Ozdag MF, Kalpakci Y, Avci IY, Besirbellioglu BA, Eyigun CP.
Intern Med. 2008;47(11):995-1001. Epub 2008 Jun 2
The p53 target protein Wig-1 binds hnRNP A2/B1 and RNA Helicase A via RNA.
Prahl M, Vilborg A, Palmberg C, Jörnvall H, Asker C, Wiman KG.
FEBS Lett. 2008 Jun 25;582(15):2173-7. Epub 2008 Jun 2
Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
[No authors listed]
Prescrire Int. 2008 Apr;17(94):54-6
Cold agglutinin-associated hemolytic anemia due to brucellosis: first case report.
Wehbe E, Moore TA.
Am J Hematol. 2008 Aug;83(8):685-6. No abstract available.
Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
Fert-Bober J, Leon H, Sawicka J, Basran RS, Devon RM, Schulz R, Sawicki G.
Basic Res Cardiol. 2008 Sep;103(5):431-43. Epub 2008 May 28
Stenotrophomonas maltophilia bacteraemia in Turkish children.
Güriz H, Ciftçi E, Ayberkin E, Aysev D, Ince E, Arsan S, Yavuz G, Doğru U.
Ann Trop Paediatr. 2008 Jun;28(2):129-36
Acute pancreatitis and subdural haematoma in a patient with severe falciparum malaria: case report and review of literature.
Seshadri P, Dev AV, Viggeswarpu S, Sathyendra S, Peter JV.
Malar J. 2008 May 30;7:97. Review
Human granulocytic ehrlichiosis complicating early pregnancy.
Muffly T, McCormick TC, Cook C, Wall J.
Infect Dis Obstet Gynecol. 2008;2008:359172
MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter.
Zurkiya O, Chan AW, Hu X.
Magn Reson Med. 2008 Jun;59(6):1225-31
Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA, Campbell CI, Petrik JJ, Moorehead RA.
Mol Cancer Res. 2008 May;6(5):819-28
Two cases of cellulitis in the course of African tick bite fever: a fortuitous association?
Bouvresse S, Del Giudice P, Franck N, Buffet M, Avril MF, Mondain V, Rolain JM, Raoult D, Dupin N.
Dermatology. 2008;217(2):140-2. Epub 2008 May 26
First Prev 117 118 119 120 121 122 123 124 125 Next Last 527/10524 Jump: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527

Back to list of medicine • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment. All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.